News

Leanne Berge, CEO of Community Health Plan of Washington in Seattle, talks to Managed Healthcare Executive about patient access challenges, COVID-19, telehealth, and health care disparities.

Health plans build strategies to ensure their beneficiaries have easy access to and receive vital immunizations.

If Pfizer's vaccine gets an emergency use authorization, it could reach sites designated by states within a day.

This week on Tuning into the C-Suite, listeners are tuning into the next feature of the Meet the Board Series where Managed Healthcare Executive Senior Editor Peter Wehrwein and Associate Editor Briana Contreras speak with MHE’s Board Member Kevin Ronneberg, M.D. Kevin is vice president and associate medical director for health initiatives at HealthPartners, an integrated, nonprofit provider and health insurance company located in Bloomington, Minnesota. During the conversation we got to learn more about Kevin, personally, and how he and his family are doing during the pandemic and his thoughts of the current issues healthcare is facing today.

Two newly approved antibody-drug conjugates and changes in radiation therapy lead the way.

There is growing recognition among healthcare providers and payers that disease prevalence is inextricably tied to social and environmental factors that impact health. In fact, clinical care accounts for an estimated 20% of health outcomes, while 80% are the result of social determinants of health (SDOH).

The Trump administration’s push to get more Medicare Shared Savings Program (MSSP) ACOs to take on downside risk is having an effect, but there are still many nontakers.

The United States usually doesn’t fare very well in international health comparisons. The country’s healthcare ranks among, if not the, most expensive. The outcomes, as measured by metrics such as life expectancy at birth, are not top tier, especially when the U.S. is compared to well-off countries in Europe and Asia.

Dr. Anthony Fauci addresses the American Heart Association Scientific Sessions.

Merck earned a new indication for pembrolizumab (Keytruda), in combination with chemotherapy, to treat locally recurrent unresectable or metastatic triple-negative breast cancer (TNBC).

Manufacturing issue creates setback for Alkermes on much-anticipated therapy that mitigates weight gain.

After an FDA denial and a lost sponsor, sotagliflozin shows it can cut cardiovascular events and possibly treat a form of heart failure that has no approved therapies.

Community-based organizations should position themselves as groups with a deep, working knowledge of an area's geography, communities and residents.

Some employers would benefit if their older employees go on Medicare, and people in their 60s would have some safety net if they can't find a job with benefits. Provider revenues might take a hit because of lower Medicare reimbursement.

A Cleveland Clinic scientist stopped short of saying doctors should take patients off Vascepa, but he said he has questions due to the lack of a "neutral comparator."

Researchers say their study is the first to look at race as a factor in how people with diabetic macular edema respond to treatment with Avastin.

Overall, the Polycap polypill (simvastatin, atenolol, hydrochlorothiazide, ramipril) falls well short of the high expectations for the polypill approach to cardiovascular disease risk reduction.

The findings are the first in a series of six studies involving a registry supported by drug makers in the diabetes, cardiovascular, and heart failure space.

Today, senior care can have a number of health benefits for the well-being of older adults. However, some family members of the patients receiving care are carrying more of the financial weight and taking care of the groundwork in their family member's care.

The first in a new class of drugs that targets the cardiac muscle is especially effective in patients with the most serious heart failure.

DocASAP’s second annual survey reveals an accelerated demand for timely, convenient care across different settings and the pandemic’s impact on care.

Starting this week, the editors of Managed Healthcare Executive® are launching a new, twice-a-month podcast about how those barriers can removed, lowered, or worked around so all patients get the healthcare they need.

Telehealth during the COVID-19 pandemic has been especially important to patients with rare disorders, many of which are autoimmune diseases, according to a recent report from the National Organization for Rare Disorders.

Pandemic prompts supply chain to focus on reducing risk, building resilience; concerns remain about data accuracy.

MHE's Briana Contreras spoke with Matthew Michela, President and CEO of Life Image, the world’s largest medical evidence and image exchange network. The two delved through the specific steps each type of healthcare organization - from health systems, payers and IT companies - must follow to comply to meet the Office of the National Coordinator for Health Information Technology (ONC) and Centers for Medicare & Medicaid Services' (CMS) new interoperability and patient access rules.

In this second of a two-part video interview with MHE, Amwell Chief Medical Officer Peter Antall says he is in favor of extending CMS waivers that made telehealth visits reimbursable and easy for patients and providers.